Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy

BACKGROUND: Glioblastoma multiforme (GBM) is a relentless primary central nervous system malignancy that remains resistant to conventional therapy despite major advances in clinical neurooncology. This report details the case of a patient who had failed conventional treatment for recurrent GBM and w...

Descripción completa

Detalles Bibliográficos
Autores principales: Whisenhunt, Thomas R, Rajneesh, Kiran F, Hackney, James R, Markert, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918376/
https://www.ncbi.nlm.nih.gov/pubmed/27512668
http://dx.doi.org/10.2147/OV.S62461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918376/
https://www.ncbi.nlm.nih.gov/pubmed/27512668
http://dx.doi.org/10.2147/OV.S62461

Ejemplares similares